Floatz logo

TERIPARATIDE

Anemia, Aplastic

The Emmes Company, LLCprotein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Anemia, Aplastic cohort.

Asset / SponsorPhaseRating
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2BB
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2B
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 26 →

Same molecule, other indications

TERIPARATIDE is also rated in:

Bartter syndrome with hypocalcemiaDormant
CCC
Indicative ·
55 / 100
View asset →
autoimmune polyendocrine syndrome type 1Dormant
CCC
Indicative ·
55 / 100
View asset →
hypoparathyroidismDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →